Skip to content

Population-based Chronic Kidney Disease Cohort at Northern Taiwan

Preventing Progression of Renal Disease by Multidisciplinary Education - A Cohort Study at Northern Taiwan.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03004898
Enrollment
10000
Registered
2016-12-29
Start date
2013-02-28
Completion date
Unknown
Last updated
2020-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease, Population, Community, Multidisciplinary, Education

Brief summary

CKD is a global endemic disease with increased comorbidities and mortality. The prevalence and the incidence of the end-stage renal disease (ESRD) are extremely high in Taiwan. The prevalence of CKD remains high; however, the awareness remains low. Screening of unique risk factor and early diagnosis of CKD can improve outcome. Furthermore, data of renal education deep into the community remains limited. The aims of this study are: 1. Explore risk factors associated with CKD in the community 2. Establish multidisciplinary care model in the community 3. Investigate mechanistic mediators for CKD and multidisciplinary education approached in behavioral , physiological, immune and metabolomics aspects 4. Provide bio-specimen repository for future study

Interventions

BEHAVIORALmultidisciplinary renal education

multidisciplinary CKD care involving case management nurse, dietitian, social worker, pharmacists.

Sponsors

Chang Gung Memorial Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

* residents of Northern Taiwan

Exclusion criteria

* pregnancy women, unwilling to participate

Design outcomes

Primary

MeasureTime frameDescription
eGFR < 60 mL/minthrough study completion, every 1 yearchange of renal function between groups
albuminuria/creatinine ratio >=30through study completion, every 1 yearchange of proteinuria between groups
proteinuria/creatine ratio >=150through study completion, every 1 yearchange of proteinuria between groups

Secondary

MeasureTime frameDescription
SF-36through study completion, every 1 yearchange of score between groups

Countries

Taiwan

Contacts

Primary ContactTsang-Tang Hsieh, MD
tth3388@adm.cgmh.org.tw+886-2-27135211
Backup ContactI-Wen Wu, MD
fliawu@yahoo.com+886-2-24313131

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026